As of 2026, Medicare Part D plans have a $2,100 annual out-of-pocket cap for prescription medications covered by your plan
The brand's Supplement Facts label includes the required FDA disclaimer: "These statements have not been evaluated by the Food and Drug Administration
AndrePPais de BarrosJPMj MerleBSamieriCHelmerCDelcourtCet al
This is especially relevant for emerging platforms such as agar-based nanoparticles, which are valued for their biocompatibility, tunable gel structure, and drug encapsulation potential
Novolog rapid-acting insulin aspart, Lantus insulin glargine) Insulin delivery devices pens, vials, or pump Insulin cooling case or mini fridge Needles and syringes Blood glucose meter, test strips, lancets, and spare batteries Insulin pump model and supplies (infusion sets, reservoirs) CGM model and sensors Medical-grade insulin cooling case or travel refrigerator Glucagon emergency kit Fast-acting sugar for hypoglycaemia management (glucose tablets, juice) Any other injectable medications (Ozempic, Mounjaro, etc.) A note about devices that require alternative security screening If your insulin pump or CGM should not go through X-ray machines or full-body scanners, this needs to be stated explicitly including the device name and model, and a request for a manual pat-down instead
